Lv4
710 积分 2021-03-22 加入
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
25天前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
25天前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
25天前
已完结
Analysis of China-to-West pharmaceutical licensing deals in 2024
28天前
已关闭
Emerging importance of HER3 in tumorigenesis and cancer therapy
1个月前
已完结
GPCR drug discovery: new agents, targets and indications
1个月前
已完结
A Roadmap to Precision Immunotherapy for Early-Stage Non–Small Cell Lung Cancer
2个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2个月前
已完结
MYC in cancer: from undruggable target to clinical trials
2个月前
已完结
皖公网安备34019202002308
